The effect of metalloprotein inhibitors on cellular metal ion content and distribution

Metallomics

Volumn 9, Issue 3, 2017, Pages 250-257

  Chen, Yao ^a,b   Lai, Barry ^c   Zhang, Zhenjie ^a,b   Cohen, Seth M ^b  

^a NANKAI UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC EMISSION SPECTROSCOPY; ENERGY DISPERSIVE SPECTROSCOPY; FLUORESCENCE MICROSCOPY; INDUCTIVELY COUPLED PLASMA; PHYSIOLOGY; PROTEINS;

CELLULAR METAL; ION CONTENT; IONS DISTRIBUTION; METAL BINDING; METAL ION HOMEOSTASIS; METALLO-PROTEINS; METALS IONS; PHARMACOPHORES; SMALL MOLECULES; THERAPEUTIC TARGETS;

METAL IONS;

METAL; METALLOPROTEIN; PROTEINASE INHIBITOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DEVICES; FLUORESCENCE; METABOLISM; MOUSE; NIH 3T3 CELL LINE; PROCEDURES; SPECTROMETRY; SYNCHROTRON;

ANIMALS; CELL SURVIVAL; FLUORESCENCE; METALLOPROTEINS; METALS; MICE; NIH 3T3 CELLS; PROTEASE INHIBITORS; SPECTROMETRY, X-RAY EMISSION; SYNCHROTRONS;

EID: 85027440810     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c6mt00267f     Document Type: Article

References (40)

1. J. J. R. Frausto da Silva, The biological chemistry of the elements: The inorganic chemistry of life, Oxford University Press, Oxford, UK, 1991.
2. S. J. Lippard and J. Berg, Principles of bioinorganic chemistry, University Science Books, Mill Valley, California, 1994.
3. D.W. Christianson and J. D. Cox, Catalysis By Metal-Activated Hydroxide in Zinc and Manganese Metalloenzymes, Annu. Rev. Biochem., 1996, 68, 25.
4. Handbook on Metalloproteins, ed. I. Bertini, A. Sigel and H. Sigel, Marcel Dekker, New York, 2001.
5. M. R. Bleackley and R. T. A. MacGillivray, Transition metal homeostasis: from yeast to human disease, BioMetals, 2011, 24(5), 785-809.
6. R. A. Colvin, B. Lai, W. R. Holmes and D. Lee, Understanding metal homeostasis in primary cultured neurons. Studies using single neuron subcellular and quantitative metallomics, Metallomics, 2015, 7(7), 1111-1123.
7. J. Wang, Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation, Nat. Chem., 2015, 7(12), 968-979.
8. K. Jomova and M. Valko, Advances inmetal-induced oxidative stress and human disease, Toxicology, 2011, 283(2-3), 65-87.
9. A. Barilli, et al., Oxidative Stress Induced by Copper and Iron Complexes with 8-Hydroxyquinoline Derivatives Causes Paraptotic Death of HeLa Cancer Cells, Mol. Pharmacol., 2014, 11(4), 1151-1163.
10. H. M. Schmitt, C. L. Schlamp and R. W. Nickells, Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells, Neurosci. Lett., 2016, 625, 11-15.
11. A. T. A. Halim, N. A. F. M. Ariffin and M. Azlan, Review: the Multiple Roles of Monocytic Microparticles, Inflammation, 2016, 39(4), 1277-1284.
12. M. Rouffet and S. M. Cohen, Emerging trends in metalloprotein inhibition, Dalton Trans., 2011, 40(14), 3445-3454.
13. Y. Yang, et al., Metalloprotein Inhibitors for the Treatment of Human Diseases, Curr. Top. Med. Chem., 2016, 16(4), 384-396.
14. Anonymous.(2016) Drug@FDA. (http://www.accessdata.fda. gov/scripts/cder/drugsatfda/index.cfm).
15. J. A. Day and S. M. Cohen, Investigating the Selectivity of Metalloenzyme Inhibitors, J. Med. Chem., 2013, 56(20), 7997-8007.
16. G. M. Rishton, Nonleadlikeness and leadlikeness in biochemical screening, Drug Discovery Today, 2003, 8(2), 86-96.
17. C. J. Vickers, C. A. Olsen, L. J. Leman and M. R. Ghadiri, Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group., ACS Med. Chem. Lett., 2012, 3(6), 505-508.
18. Y. Chen and S. M. Cohen, Investigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins, ChemMedChem, 2015, 10(10), 1733-1738.
19. K. W. Bruhn and B. Spellberg, Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections, Curr. Opin. Microbiol., 2015, 27, 57-61.
20. J. L. Vinkenborg, M. S. Koay and M. Merkx, Fluorescent imaging of transition metal homeostasis using genetically encoded sensors, Curr. Opin. Chem. Biol., 2010, 14(2), 231-237.
21. E. L. Que, et al., Quantitative mapping of zinc fluxes in the mammalian egg reveals the origin of fertilization-induced zinc sparks, Nat. Chem., 2015, 7(2), 130-139.
22. C. J. Fahrni, Biological applications of X-ray fluorescence microscopy: exploring the subcellular topography and speciation of transition metals, Curr. Opin. Chem. Biol., 2007, 11(2), 121-127.
23. Z. Qin, J. A. Caruso, B. Lai, A. Matusch and J. S. Becker, Trace metal imaging with high spatial resolution: Applications in biomedicine, Metallomics, 2011, 3(1), 28-37.
24. R. McRae, P. Bagchi, S. Sumalekshmy and C. J. Fahrni, In Situ Imaging of Metals in Cells and Tissues, Chem. Rev., 2009, 109(10), 4780-4827.
25. A. Carmona, S. Roudeau, L. Perrin, G. Veronesi and R. Ortega, Environmental manganese compounds accumulate as Mn(ii) within the Golgi apparatus of dopamine cells: relationship between speciation, subcellular distribution, and cytotoxicity, Metallomics, 2014, 6(4), 822-832.
26. R. McRae (2010) Investigating metal homestasis in mammalian cells using high resolution imaging techniques.(https://smar tech.gatech.edu/handle/1853/41197).
27. L. Yang, et al., Imaging of the intracellular topography of copper with a fluorescent sensor and by synchrotron x-ray fluorescence microscopy, Proc. Natl. Acad. Sci. U. S. A., 2005, 102(32), 11179-11184.
28. M. Namdar, et al., Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents., Proc. Natl. Acad. Sci. U. S. A., 2010, 107(46), 20003-20008.
29. B. S. Twining, et al., Quantifying Trace Elements in Individual Aquatic Protist Cells with a Synchrotron X-ray Fluorescence Microprobe, Anal. Chem., 2003, 75(15), 3806-3816.
30. M. D. Hall, et al., The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours, J. Struct. Biol., 2006, 155(1), 38-44.
31. M. J. Brady, F. J. Bourbonais and A. R. Saltiel, The Activation of Glycogen Synthase by Insulin Switches from Kinase Inhibition to Phosphatase Activation during Adipogenesis in 3T3-L1 Cells, J. Biol. Chem., 1998, 273(23), 14063-14066.
32. Y. Samuni, W. Flores-Santana, M. C. Krishna, J. B. Mitchell and D. A. Wink, The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation, Free Radical Biol. Med., 2009, 47(4), 419-423.
33. V.M. Richon, et al., Second generation hybrid polar compounds are potent inducers of transformed cell differentiation, Proc. Natl. Acad. Sci. U. S. A., 1996, 93(12), 5705-5708.
34. B. E. L. Lauffer, et al., Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability, J. Biol. Chem., 2013, 288, 26926-26943.
35. H. Hess-Stumpp, Histone deacetylase inhibitors and cancer: from cell biology to the clinic, Eur. J. Cell Biol., 2005, 84(2-3), 109-121.
36. M. Lobera, et al., Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group, Nat. Chem. Biol., 2013, 9(5), 319-325.
37. K. Shirahama, Y. Yazaki, K. Sakano, Y. Wada and Y. Ohsumi, Vacuolar Function in the Phosphate Homeostasis of the Yeast Saccharomyces cerevisiae, Plant Cell Physiol., 1996, 37(8), 1090-1093.
38. S. Vogt, MAPS: A set of software tools for analysis and visualization of 3D X-ray fluorescence data sets, J. Phys. IV, 2003, 104, 4.
39. P. Shi, et al., Synapse microarray identification of small molecules that enhance synaptogenesis, Nat. Commun., 2011, 2, 510.
40. T. Zor and Z. Selinger, Linearization of the Bradford Protein Assay Increases Its Sensitivity: Theoretical and Experimental Studies, Anal. Chem., 1996, 236(2), 302-308.